Global Herceptin Biosimilar Market Research Report 2019

Table of Contents

Executive Summary

1 Herceptin Biosimilar Market Overview

• 1.1 Product Overview and Scope of Herceptin Biosimilar
• 1.2 Herceptin Biosimilar Segment by Type
  • 1.2.1 Global Herceptin Biosimilar Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Breast Cancer
  • 1.2.3 Colorectal Cancer
  • 1.2.4 Leukemia
  • 1.2.5 Lymphoma
  • 1.2.6 Other
• 1.3 Herceptin Biosimilar Segment by Application
  • 1.3.1 Herceptin Biosimilar Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital & Clinics
  • 1.3.3 Oncology Centers
  • 1.3.4 Other
• 1.4 Global Herceptin Biosimilar Market by Region
  • 1.4.1 Global Herceptin Biosimilar Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Herceptin Biosimilar Market Size
  • 1.5.1 Global Herceptin Biosimilar Revenue (2014-2025)
  • 1.5.2 Global Herceptin Biosimilar Production (2014-2025)

2 Global Herceptin Biosimilar Market Competition by Manufacturers

• 2.1 Global Herceptin Biosimilar Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Herceptin Biosimilar Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Herceptin Biosimilar Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Herceptin Biosimilar Production Sites, Area Served, Product Types
• 2.5 Herceptin Biosimilar Market Competitive Situation and Trends
  • 2.5.1 Herceptin Biosimilar Market Concentration Rate
  • 2.5.2 Herceptin Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Herceptin Biosimilar Production Market Share by Regions

• 3.1 Global Herceptin Biosimilar Production Market Share by Regions
• 3.2 Global Herceptin Biosimilar Revenue Market Share by Regions (2014-2019)
• 3.3 Global Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Herceptin Biosimilar Production
  • 3.4.1 North America Herceptin Biosimilar Production Growth Rate (2014-2019)
  • 3.4.2 North America Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Herceptin Biosimilar Production
  • 3.5.1 Europe Herceptin Biosimilar Production Growth Rate (2014-2019)
  • 3.5.2 Europe Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Herceptin Biosimilar Production
  • 3.6.1 China Herceptin Biosimilar Production Growth Rate (2014-2019)
  • 3.6.2 China Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Herceptin Biosimilar Production
  • 3.7.1 Japan Herceptin Biosimilar Production Growth Rate (2014-2019)
  • 3.7.2 Japan Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Herceptin Biosimilar Consumption by Regions

• 4.1 Global Herceptin Biosimilar Consumption by Regions
• 4.2 North America Herceptin Biosimilar Consumption (2014-2019)
• 4.3 Europe Herceptin Biosimilar Consumption (2014-2019)
• 4.4 China Herceptin Biosimilar Consumption (2014-2019)
• 4.5 Japan Herceptin Biosimilar Consumption (2014-2019)

5 Global Herceptin Biosimilar Production, Revenue, Price Trend by Type

• 5.1 Global Herceptin Biosimilar Production Market Share by Type (2014-2019)
• 5.2 Global Herceptin Biosimilar Revenue Market Share by Type (2014-2019)
• 5.3 Global Herceptin Biosimilar Price by Type (2014-2019)
• 5.4 Global Herceptin Biosimilar Production Growth by Type (2014-2019)

6 Global Herceptin Biosimilar Market Analysis by Applications

• 6.1 Global Herceptin Biosimilar Consumption Market Share by Application (2014-2019)
• 6.2 Global Herceptin Biosimilar Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Herceptin Biosimilar Business

• 7.1 Amgen
  • 7.1.1 Amgen Herceptin Biosimilar Production Sites and Area Served
  • 7.1.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.1.3 Amgen Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 AryoGen Biopharma
  • 7.2.1 AryoGen Biopharma Herceptin Biosimilar Production Sites and Area Served
  • 7.2.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.2.3 AryoGen Biopharma Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biocon
  • 7.3.1 Biocon Herceptin Biosimilar Production Sites and Area Served
  • 7.3.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.3.3 Biocon Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Celltrion
  • 7.4.1 Celltrion Herceptin Biosimilar Production Sites and Area Served
  • 7.4.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.4.3 Celltrion Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Gedeon Richter
  • 7.5.1 Gedeon Richter Herceptin Biosimilar Production Sites and Area Served
  • 7.5.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.5.3 Gedeon Richter Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Genor Biopharma
  • 7.6.1 Genor Biopharma Herceptin Biosimilar Production Sites and Area Served
  • 7.6.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.6.3 Genor Biopharma Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Mabion
  • 7.7.1 Mabion Herceptin Biosimilar Production Sites and Area Served
  • 7.7.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.7.3 Mabion Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.8 Mylan
  • 7.8.1 Mylan Herceptin Biosimilar Production Sites and Area Served
  • 7.8.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.8.3 Mylan Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Roche
  • 7.9.1 Roche Herceptin Biosimilar Production Sites and Area Served
  • 7.9.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.9.3 Roche Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 The Instituto Vital Brazil
  • 7.10.1 The Instituto Vital Brazil Herceptin Biosimilar Production Sites and Area Served
  • 7.10.2 Herceptin Biosimilar Product Introduction, Application and Specification
  • 7.10.3 The Instituto Vital Brazil Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Herceptin Biosimilar Manufacturing Cost Analysis

• 8.1 Herceptin Biosimilar Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Herceptin Biosimilar
• 8.4 Herceptin Biosimilar Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Herceptin Biosimilar Distributors List
• 9.3 Herceptin Biosimilar Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Herceptin Biosimilar Market Forecast

• 11.1 Global Herceptin Biosimilar Production, Revenue Forecast
  • 11.1.1 Global Herceptin Biosimilar Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Herceptin Biosimilar Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Herceptin Biosimilar Price and Trend Forecast (2019-2025)
• 11.2 Global Herceptin Biosimilar Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
• 11.3 Global Herceptin Biosimilar Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Herceptin Biosimilar Consumption Forecast (2019-2025)
  • 11.3.2 Europe Herceptin Biosimilar Consumption Forecast (2019-2025)
  • 11.3.3 China Herceptin Biosimilar Consumption Forecast (2019-2025)
  • 11.3.4 Japan Herceptin Biosimilar Consumption Forecast (2019-2025)
• 11.4 Global Herceptin Biosimilar Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Herceptin Biosimilar Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List